PTC Therapeutics (PTCT) Quick Ratio: History & Chart

PTC Therapeutics, Inc.(PTCT)

Biotechnology · Warren, NJ

$63.70+0.05 (+0.08%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications. Among its commercialized products, PTC Therapeutics provides Translarna and Emflaza, offering therapeutic options for Duchenne muscular dystrophy patients in the European Economic Area and the United States. Translarna also addresses nonsense mutation Duchenne muscular dystrophy in Brazil and Russia. The company additionally commercializes Tegsedi and Waylivra for various rare conditions throughout Latin America and the Caribbean. Furthermore, in Brazil, PTC Therapeutics distributes Evrysdi as a treatment for spinal muscular atrophy (SMA) in patients aged two months and older. Leveraging its proprietary splicing platform, the company is also actively developing PTC518, a promising therapeutic candidate aimed at treating Huntington's disease. To bolster its research and development capabilities, PTC Therapeutics has established strategic collaborations, including partnerships with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation, focusing on advancing drug discovery and development research, particularly in regenerative medicine. Additionally, it collaborates with Akcea Therapeutics, Inc. for the commercialization of Tegsedi and Waylivra in the Latin America and Caribbean region. Established in 1998, PTC Therapeutics, Inc. maintains its corporate headquarters in South Plainfield, New Jersey.

Warren, NJ

991 employees

www.ptcbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Matthew Klein

View full financials

PTCT Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

3.28

QUICK RATIO (ACID-TEST) AVG TTM

2.74

QUICK RATIO (ACID-TEST) AVG 3Y

2.17

QUICK RATIO (ACID-TEST) AVG 5Y

1.88

QUICK RATIO (ACID-TEST) AVG 10Y

2.87

QUICK RATIO (ACID-TEST) AVG 15Y

3.16

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+19.36%

CURRENT VS 3Y AVG

+50.98%

CURRENT VS 5Y AVG

+74.56%

CURRENT VS 10Y AVG

+13.98%

CURRENT VS 15Y AVG

+3.75%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 870 covered companies

CURRENT VS SECTOR MEDIAN

-2.36%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
PTC Therapeutics, Inc. (PTCT)	$5.32B	3.28	2.74	2.17	1.88
CRISPR Therapeutics AG (CRSP)vs ›	$5.21B	17.85	17.70	17.06	17.77
Travere Therapeutics, Inc. (TVTX)vs ›	$5.21B	3.99	2.37	2.88	3.42
Sotera Health Company (SHC)vs ›	$5.20B	2.53	2.36	1.93	1.92
Doximity, Inc. (DOCS)vs ›	$5.20B	6.08	6.53	6.56	6.07
Cogent Biosciences, Inc. (COGT)vs ›	$5.19B	13.57	9.78	9.13	11.38
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.52B	1.36	1.16	1.16	1.16
RadNet, Inc. (RDNT)vs ›	$5.53B	1.48	1.94	1.50	1.26
Scholar Rock Holding Corporation (SRRK)vs ›	$5.09B	7.02	8.28	8.59	7.77
Merit Medical Systems, Inc. (MMSI)vs ›	$5.07B	2.79	2.90	2.74	2.21

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

PTC Therapeutics, Inc. (PTCT)

$5.32B

3.28

2.74

2.17

1.88

CRISPR Therapeutics AG (CRSP)vs ›

$5.21B

17.85

17.70

17.06

17.77

Travere Therapeutics, Inc. (TVTX)vs ›

$5.21B

3.99

2.37

2.88

3.42

Sotera Health Company (SHC)vs ›

$5.20B

2.53

2.36

1.93

1.92

Doximity, Inc. (DOCS)vs ›

$5.20B

6.08

6.53

6.56

6.07

Cogent Biosciences, Inc. (COGT)vs ›

$5.19B

13.57

9.78

9.13

11.38

MiniMed Group, Inc. Common Stock (MMED)vs ›

$5.52B

1.36

1.16

RadNet, Inc. (RDNT)vs ›

$5.53B

1.48

1.94

1.50

1.26

Scholar Rock Holding Corporation (SRRK)vs ›

$5.09B

7.02

8.28

8.59

7.77

Merit Medical Systems, Inc. (MMSI)vs ›

$5.07B

2.79

2.90

2.74

2.21

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for PTC Therapeutics, Inc. (PTCT)?

The quick ratio (acid-test) for PTCT stock is 3.28.

Is PTC Therapeutics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 3.28 is 75% above its 5-year average of 1.88, near the high end of its 5-year range (1.03–3.85).

What is the TTM average quick ratio (acid-test) for PTC Therapeutics, Inc. (PTCT)?

The TTM average quick ratio (acid-test) for PTCT stock is 2.74.

What is the 3Y average quick ratio (acid-test) for PTC Therapeutics, Inc. (PTCT)?

The 3Y average quick ratio (acid-test) for PTCT stock is 2.17.

What is the 5Y average quick ratio (acid-test) for PTC Therapeutics, Inc. (PTCT)?

The 5Y average quick ratio (acid-test) for PTCT stock is 1.88.

What is the 10Y average quick ratio (acid-test) for PTC Therapeutics, Inc. (PTCT)?

The 10Y average quick ratio (acid-test) for PTCT stock is 2.87.

What is the 15Y average quick ratio (acid-test) for PTC Therapeutics, Inc. (PTCT)?

The 15Y average quick ratio (acid-test) for PTCT stock is 3.16.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	3.28
2026-03-31	2.36
2025-12-31	2.27
2025-09-30	2.26
2025-06-30	3.57
2025-03-31	3.85
2024-12-31	2.31
2024-09-30	2.04
2024-06-30	2.17
2024-03-31	1.98
2023-12-31	1.97
2023-09-30	1.03
2023-06-30	1.17
2023-03-31	1.33
2022-12-31	1.65
2022-09-30	1.20
2022-06-30	1.20
2022-03-31	1.59
2021-12-31	1.84
2021-09-30	2.14
2021-06-30	3.61
2021-03-31	4.41
2020-12-31	4.37
2020-09-30	4.83
2020-06-30	2.91
2020-03-31	3.09
2019-12-31	3.22
2019-09-30	4.30
2019-06-30	2.63
2019-03-31	3.24
2018-12-31	1.83
2018-09-30	2.61
2018-06-30	4.18
2018-03-31	3.16
2017-12-31	2.90
2017-09-30	2.97
2017-06-30	3.24
2017-03-31	5.27
2016-12-31	5.27
2016-09-30	5.74
2016-06-30	6.93
2016-03-31	7.44
2015-12-31	7.84
2015-09-30	12.12
2015-06-30	11.46
2015-03-31	12.12
2014-12-31	9.96
2014-09-30	12.37
2014-06-30	19.88
2014-03-31	26.99
2013-12-31	11.04
2013-09-30	11.50
2013-06-30	8.50
2013-03-31	2.07
2012-12-31	0.16
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

3.28

2026-03-31

2.36

2025-12-31

2.27

2025-09-30

2.26

2025-06-30

3.57

2025-03-31

3.85

2024-12-31

2.31

2024-09-30

2.04

2024-06-30

2.17

2024-03-31

1.98

2023-12-31

1.97

2023-09-30

1.03

2023-06-30

1.17

2023-03-31

1.33

2022-12-31

1.65

2022-09-30

1.20

2022-06-30

1.20

2022-03-31

1.59

2021-12-31

1.84

2021-09-30

2.14

2021-06-30

3.61

2021-03-31

4.41

2020-12-31

4.37

2020-09-30

4.83

2020-06-30

2.91

2020-03-31

3.09

2019-12-31

3.22

2019-09-30

4.30

2019-06-30

2.63

2019-03-31

3.24

2018-12-31

1.83

2018-09-30

2.61

2018-06-30

4.18

2018-03-31

3.16

2017-12-31

2.90

2017-09-30

2.97

2017-06-30

3.24

2017-03-31

5.27

2016-12-31

5.27

2016-09-30

5.74

2016-06-30

6.93

2016-03-31

7.44

2015-12-31

7.84

2015-09-30

12.12

2015-06-30

11.46

2015-03-31

12.12

2014-12-31

9.96

2014-09-30

12.37

2014-06-30

19.88

2014-03-31

26.99

2013-12-31

11.04

2013-09-30

11.50

2013-06-30

8.50

2013-03-31

2.07

2012-12-31

0.16

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

Quick Ratio (Acid-Test): 3.28

PTCT Quick Ratio

PTCT Average Quick Ratio (Acid-Test) Chart

PTCT Current vs Average Quick Ratio (Acid-Test) Chart

PTCT Quick Ratio (Acid-Test) Metrics

PTCT Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

PTCT Quick Ratio (Acid-Test) History

Related Metrics